HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT
0.0.1 - DRAFT
HL7 FHIR Implementation Guide: Common Terminology Criteria (CTC) Adverse Events Release 1 - DRAFT, published by HL7 International Clinical Interoperability Council. This guide is not an authorized publication; it is the continuous build for version 0.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/standardhealth/fsh-ae/ and changes regularly. See the Directory of published versions
<MedicationRequest xmlns="http://hl7.org/fhir">
<id value="medication-request-example-tucatinib"/>
<meta>
<profile
value="http://hl7.org/fhir/us/mcode/StructureDefinition/mcode-cancer-related-medication-request"/>
</meta>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="medication-request-example-tucatinib"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest "medication-request-example-tucatinib" </p><p style="margin-bottom: 0px">Profile: <a href="http://hl7.org/fhir/us/mcode/2021May/StructureDefinition-mcode-cancer-related-medication-request.html">Cancer-Related Medication Request</a></p></div><p><b>status</b>: active</p><p><b>intent</b>: order</p><p><b>medication</b>: tucatinib 150 MG Oral Tablet <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.3.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#2361290)</span></p><p><b>subject</b>: <a href="Patient-patient-example-kaitlyn-b.html">Patient/patient-example-kaitlyn-b</a> " BOUNCE"</p><p><b>authoredOn</b>: 2020-03-12</p><p><b>requester</b>: <a href="Practitioner-PractitionerExample1.html">Practitioner/PractitionerExample1</a> " ANYDOC"</p><p><b>reasonReference</b>: <a href="Condition-KaitlynPrimaryCancerConditionEx1.html">Condition/KaitlynPrimaryCancerConditionEx1</a></p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: oral twice a day every day</p><p><b>timing</b>: Starting 2020-04-01, Once</p><p><b>route</b>: Oral route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#26643006)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote><p><b>maxDosePerAdministration</b>: 2</p></blockquote></div>
</text>
<status value="active"/>
<intent value="order"/>
<medicationCodeableConcept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="2361290"/>
<display value="tucatinib 150 MG Oral Tablet"/>
</coding>
</medicationCodeableConcept>
<subject>🔗
<reference value="Patient/patient-example-kaitlyn-b"/>
</subject>
<authoredOn value="2020-03-12"/>
<requester>🔗
<reference value="Practitioner/PractitionerExample1"/>
</requester>
<reasonReference>🔗
<reference value="Condition/KaitlynPrimaryCancerConditionEx1"/>
</reasonReference>
<dosageInstruction>
<text value="oral twice a day every day"/>
<timing>
<repeat>
<boundsPeriod>
<start value="2020-04-01"/>
</boundsPeriod>
</repeat>
</timing>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="26643006"/>
<display value="Oral route (qualifier value)"/>
</coding>
</route>
<doseAndRate>
<rateQuantity>
<value value="150"/>
<unit value="MG"/>
<system value="http://unitsofmeasure.org"/>
<code value="MG"/>
</rateQuantity>
</doseAndRate>
<maxDosePerAdministration>
<value value="2"/>
</maxDosePerAdministration>
</dosageInstruction>
</MedicationRequest>